EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Tumour‐derived exosomes in liver metastasis: A Pandora's box

Sini Li, Yan Qu, Lihui Liu, Chao Wang, Li Yuan, Hua Bai, Jie Wang iD

Cell Proliferation · 2023

DOI: 10.1111/cpr.13452 ↗

At a glance

Systematische Übersicht in Cell Proliferation, 2023. Written by Sini Li and 6 co-authors. Institution: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Major MEDLINE topics: Exosomes, Liver Neoplasms. Cited 20 times so far (Crossref); 142 references. The full text is freely available (open access, CC BY 4.0). Funded by: Aiyou foundation, CAMS Innovation Fund for Medical Sciences, CAMS Key Laboratory of Translational Research on Lung Cancer.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The liver is a common secondary metastasis site of many malignant tumours, such as the colorectum, pancreas, stomach, breast, prostate, and lung cancer. The clinical management of liver metastases is challenging because of their strong heterogeneity, rapid progression, and poor prognosis. Now, exosomes, small membrane vesicles that are 40–160 nm in size, are released by tumour cells, namely, tumour‐derived exosomes (TDEs), and are being increasingly studied because they can retain the original characteristics of tumour cells. Cell–cell communication via TDEs is pivotal for liver pre‐metastatic niche (PMN) formation and liver metastasis; thus, TDEs can provide a theoretical basis to intensively study the potential mechanisms of liver metastasis and new insights into the diagnosis and treatment of liver metastasis. Here, we systematically review current research progress about the roles and possible regulatory mechanisms of TDE cargos in liver metastasis, focusing on the functions of TDEs in liver PMN formation. In addition, we discuss the clinical utility of TDEs in liver metastasis, including TDEs as potential biomarkers, and therapeutic approaches for future research reference in this field.

Subjects

MeSH terms (MEDLINE)

ExosomesLiver NeoplasmsHumansCell CommunicationPancreasBiomarkers, TumorTumor MicroenvironmentNeoplasm Metastasis

Substances

Biomarkers, Tumor

Authors and institutions

  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospit…

ORCID profiles: Jie Wang

Funding

  • Aiyou foundation
  • CAMS Innovation Fund for Medical Sciences
  • CAMS Key Laboratory of Translational Research on Lung Cancer
  • National key R&D program of China
  • National key research and development project
  • NSFC general program
  • NSFC special program
  • National Key Research and Development Program of China

Cite

APA

Li, S., Qu, Y., Liu, L., Wang, C., Yuan, L., Bai, H., & Wang, J. (2023). Tumour‐derived exosomes in liver metastasis: A Pandora's box. Cell Proliferation. https://doi.org/10.1111/cpr.13452

Vancouver

Li S, Qu Y, Liu L, Wang C, Yuan L, Bai H, et al. Tumour‐derived exosomes in liver metastasis: A Pandora's box. Cell Proliferation. 2023. doi:10.1111/cpr.13452

BibTeX
@article{Li2023,
  author = {Li, Sini and Qu, Yan and Liu, Lihui and Wang, Chao and Yuan, Li and Bai, Hua and Wang, Jie},
  title = {Tumour‐derived exosomes in liver metastasis: A Pandora's box},
  journal = {Cell Proliferation},
  year = {2023},
  doi = {10.1111/cpr.13452}
}
Start for free →